Preoperative and Postoperative Comparison of Two Nerve Blocks in Intertrochanteric Fracture Surgery

A prospective observational study was planned to be conducted in the operating room of Erzincan Mengücek Gazi Training and Research Hospital. The study will be initiated after approval from the university ethics committee and written informed consent from the patients. A minimum of 64 patients aged 30-85 with elective intertrochanteric femur fractures scheduled for surgery under spinal anesthesia by the orthopedic clinic and ASA I, II, or III will be included in the study. Patients with an ASA risk score of IV or higher, those undergoing emergency surgery, those who refused the study or wished to withdraw later, those with Alzheimer's dementia delirium-like cognitive dysfunction, those with a history of local anesthetic drug toxicity, those with an infection at the block site, those with bleeding diatheses, those undergoing additional surgery or additional anesthetic procedures (general anesthesia), those with a history of chronic opioid use, and those receiving neuropathic pain medication will be excluded from the study. The study will be conducted over a 6-month period from May 19, 2025, to November 19, 2025. All patients will be informed about the study protocol and the procedures to be performed the day before surgery, and written informed consent will be obtained. Patients who are admitted to the preoperative preparation room in the operating room and who undergo routine preoperative monitoring and receive routine ultrasound-guided pericapsular nerve block (PENG) will be included in Group P, and those who undergo routine ultrasound-guided anterior quadratus lumborum block (QLB-3) will be included in Group Q. As is the routine perioperative approach, nasal oxygen will be administered at 2 L/min.

Patients will be transferred to the operating table for spinal anesthesia 30 minutes after the block. Hemodynamic data (SpO2, blood pressure, and pulse rate) will be recorded as is the routine preoperative and intraoperative process. During this process, the patient's resting pain before the block, dynamic pain before the block (leg pain at 15 degrees of elevation), resting pain at 30 minutes after the block, dynamic pain at 30 minutes after the block (leg pain at 15 degrees of elevation), and pain in the given position during spinal anesthesia will be recorded using a numerical rating scale (NRS). (The Numerical Rating Scale (NRS) is a pain score used to rate pain. During this score measurement, patients are asked to verbally state a number that corresponds to their pain, place a check mark on the number indicating their pain, or point to the number. The scale ranges from 0 to 10. 0 indicates no pain, while 10 represents the worst possible pain. Additionally, the anesthesiologist's block application times and whether spinal anesthesia was successful on the first attempt will be recorded. Patients in each group will be included in the group based on their demographic characteristics. After the procedure, patients will be admitted to the postoperative care unit as usual. Patients with an Aldrete score >9 will be transferred to the ward (The Aldrete Scoring System is a scoring system that reflects physiological recovery after anesthesia. This system examines five parameters: muscle activity, respiration, circulation, consciousness, and oxygen saturation. Each parameter is assigned a score of 0, 1, or 2, with a maximum total score of 10).

Patients' rest pain will be assessed and recorded using a numerical rating scale (NRS) at 1 hour, 4 hours, 8 hours, 12 hours, and 24 hours postoperatively. All patients will be routinely administered 50 mg dexketoprofen intravenously three times daily for postoperative analgesia. Additionally, as is routinely done for postoperative pain management in our hospital's orthopedic department, 1 mg/kg tramadol will be administered intravenously as rescue analgesia if the patient's Numerical Rating Scale (NRS) score is 4 or higher (Rescue analgesia is an additional analgesic procedure performed when pain persists despite routine analgesic treatment). Tramadol dosing intervals will be planned to be no less than 6 hours, and the maximum daily tramadol dose will not exceed 400 mg. The total number of analgesic medications (NSAIDs or opioids) used in addition to the nerve block administered for pain control within 24 hours postoperatively will be recorded. For postoperative patient monitoring, patients will be evaluated by a physician who is unaware of the type of block administered.